{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:26:03Z","timestamp":1759991163177,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1006\/clin.1998.4602","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"231-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment with Progesterone Analogues Decreases Macrophage Fc\u03b3 Receptors Expression"],"prefix":"10.1006","volume":"89","author":[{"given":"F.","family":"Gomez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Michan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1998.4602_II984602RF1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.1780280202","article-title":"Sex steroids and rheumatic diseases","volume":"28","author":"Lahita","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1998.4602_II984602RF2","first-page":"454","article-title":"Thrombocytopenic purpura in pregnancy","volume":"4","author":"Peterson","year":"1954","journal-title":"Obstet. Gynecol."},{"key":"10.1006\/clin.1998.4602_II984602RF3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00006254-196310000-00001","article-title":"Idiopathic thrombocytopenic purpura and pregnancy","volume":"18","author":"Goodhue","year":"1962","journal-title":"Obstet. Gynecol. Surg."},{"key":"10.1006\/clin.1998.4602_II984602RF4","series-title":"The Clinical Management of Systemic Lupus Erythematosus","article-title":"SLE and pregnancy","author":"Zurier","year":"1983"},{"key":"10.1006\/clin.1998.4602_II984602RF5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/art.1780261215","article-title":"Increased oxidation of testosterone in systemic lupus erythematosus","volume":"26","author":"Lahita","year":"1983","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clin.1998.4602_II984602RF6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1172\/JCI111669","article-title":"Effect of estradiol and steroid analogues on the clearance of immunoglobulin G coated erythrocytes","volume":"75","author":"Friedman","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF7","first-page":"162","article-title":"Effects of testosterone, estradiol and progesterone on immune regulation","volume":"47","author":"Holdstock","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-065X.1983.tb01093.x","article-title":"Steroids as immunosuppressants in pregnancy","volume":"75","author":"Stites","year":"1983","journal-title":"Immunol. Rev."},{"key":"10.1006\/clin.1998.4602_II984602RF9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod26.1.1","article-title":"Immunologic and endocrine interrelationships in pregnancy","volume":"26","author":"Shteri","year":"1982","journal-title":"Biol. Reprod."},{"key":"10.1006\/clin.1998.4602_II984602RF10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1126\/science.3871252","article-title":"Interaction between the gonadal steroids and the immune system","volume":"227","author":"Grossman","year":"1985","journal-title":"Science"},{"key":"10.1006\/clin.1998.4602_II984602RF11","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1084\/jem.147.6.1684","article-title":"Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages","volume":"147","author":"Werb","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0074-7696(08)60202-8","article-title":"The effects of steroid hormones on macrophage activity","volume":"25","author":"Vernon-Roberts","year":"1969","journal-title":"Int. Rev. Cytol."},{"key":"10.1006\/clin.1998.4602_II984602RF13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/eji.1830111008","article-title":"Clearance of sensitized erythrocytes in NZB\/NZW mice: Effects of castration and sex hormone treatment","volume":"11","author":"Shear","year":"1981","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF14","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.4049\/jimmunol.141.9.2959","article-title":"Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells","volume":"141","author":"Schreiber","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1172\/JCI107325","article-title":"Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes","volume":"52","author":"Atkinson","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI108196","article-title":"Effect of corticosteroids on the human monocyte IgG and complement receptors","volume":"56","author":"Schreiber","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF17","first-page":"192","article-title":"Impairment of splenic macrophage Fc\u03b3 receptor function by progesterone analogues","volume":"26","author":"Gomez","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI106846","article-title":"Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites","volume":"81","author":"Schreiber","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI115271","article-title":"In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc\u03b3 receptors","volume":"88","author":"Ruiz","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3181\/00379727-94-22929","article-title":"Effects of 2-methylation on glucocorticoid activity of various C-21 steroids","volume":"94","author":"Dulin","year":"1957","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI106847","article-title":"Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum","volume":"51","author":"Schreiber","year":"1972","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0161-5890(87)90112-X","article-title":"Demonstration of the evidence of two distinct Fc receptors for IgG isotypes on guinea pig macrophages by the use of monoclonal antibodies","volume":"24","author":"Shimamura","year":"1987","journal-title":"Mol. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1977.tb29429.x","article-title":"Glucocorticoid activity of various progesterone analogues. Correlation between specific binding in thymus and liver and biologic activity","volume":"206","author":"DiSorbo","year":"1977","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/clin.1998.4602_II984602RF24","series-title":"Biochemistry of Steroids and Other Isopentenoids","first-page":"535","article-title":"Function of steroids","author":"Nes","year":"1977"},{"key":"10.1006\/clin.1998.4602_II984602RF25","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/1097-0142(19890515)63:10<1938::AID-CNCR2820631012>3.0.CO;2-S","article-title":"High-dose medroxyprogesterone acetate in advanced breast cancer","volume":"63","author":"Becher","year":"1989","journal-title":"Cancer"},{"key":"10.1006\/clin.1998.4602_II984602RF26","first-page":"48","article-title":"High-dose medroxyprogesterone acetate for the treatment of advanced breast cancer: Dose and toxicities","volume":"24","author":"Aisner","year":"1987","journal-title":"Semin. Hematol."},{"key":"10.1006\/clin.1998.4602_II984602RF27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.1987.03390090067026","article-title":"High-dose megestrol acetate: A possible treatment for cachexia","volume":"257","author":"Tchekmedyian","year":"1987","journal-title":"JAMA"},{"key":"10.1006\/clin.1998.4602_II984602RF28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.2820690532","article-title":"Megestrol acetate in cancer anorexia and weight loss","volume":"69","author":"Tchekmedyian","year":"1992","journal-title":"Cancer"},{"key":"10.1006\/clin.1998.4602_II984602RF29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","article-title":"Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia","volume":"82","author":"Loprinzi","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/clin.1998.4602_II984602RF30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000421-198904000-00013","article-title":"A prospective randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma","volume":"12","author":"Creagan","year":"1989","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1006\/clin.1998.4602_II984602RF31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-109-10-840","article-title":"Megestrol acetate for the treatment of cachexia associated with human immunodeficiency virus (HIV) infection","volume":"109","author":"Von Roenm","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","article-title":"Megestrol acetate in patients with AIDS-related cachexia","volume":"121","author":"Von Roenm","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-121-6-199409150-00002","article-title":"Megestrol acetate in patients with AIDS and cachexia","volume":"121","author":"Oster","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF34","unstructured":"World Health Organization, Oral Contraceptives and Neoplasia, 1992"},{"key":"10.1006\/clin.1998.4602_II984602RF35","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women","volume":"332","author":"Colditz","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-120-10-199405150-00002","article-title":"Oral contraceptive use and mortality during 12 years follow-up: The nurses' health study","volume":"120","author":"Colditz","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19950101)75:1<1::AID-CNCR2820750102>3.0.CO;2-1","article-title":"Menopausal estrogens replacement therapy in women with breast cancer","volume":"75","author":"Pritchard","year":"1995","journal-title":"Cancer"},{"key":"10.1006\/clin.1998.4602_II984602RF38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(94)92642-5","article-title":"Hormonal treatment for the climateric: Alleviation of symptoms and prevention of postmenopausal disease","volume":"343","author":"Velde","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1998.4602_II984602RF39","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archinte.1994.00420100084011","article-title":"Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations","volume":"154","author":"Sacks","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF40","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(94)90567-3","article-title":"Oral contraceptive use and adenocarcinoma of cervix","volume":"344","author":"Ursin","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1998.4602_II984602RF41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(94)92826-6","article-title":"Oral contraceptive and risk of breast cancer in women aged 20\u201354 years","volume":"344","author":"Rookus","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1998.4602_II984602RF42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9343(94)90050-7","article-title":"Postmenopausal estrogen replacement: A long-term cohort study","volume":"97","author":"Lafferty","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJM199404143301508","article-title":"Hormonal treatmente of postmenopausal women","volume":"330","author":"Belchetz","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF44","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM199411033311806","article-title":"The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers","volume":"331","author":"Polaneczky","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jama.1994.03520070060039","article-title":"Estrogen replacement therapy in breast cancer survivors. A time for change","volume":"272","author":"Cobleigh","year":"1994","journal-title":"JAMA"},{"key":"10.1006\/clin.1998.4602_II984602RF46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.1994.00420120047005","article-title":"The risk of myocardial infarction associated with the combined use of estrigens and progestins in postmenopausal women","volume":"154","author":"Psaty","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF47","first-page":"67","article-title":"Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin alteration","volume":"31","author":"Schreiner","year":"1976","journal-title":"Adv. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF48","first-page":"218","article-title":"Megestrol acetate treatment of symptomatic HIV-1 associated thrombocytopenia","volume":"22","author":"Ruiz","year":"1992","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1006\/clin.1998.4602_II984602RF49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM199411033311807","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"331","author":"George","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF50","first-page":"761","article-title":"Trombocitopenia asociada a la infecci\u00f3n por el virus de la immunodeficiencia humana. Estudio immunol\u00f3gico de 60 pacientes adictos a drogas por via parenteral","volume":"101","author":"Mu\u00f1iz-Diaz","year":"1993","journal-title":"Med. Clin."},{"key":"10.1006\/clin.1998.4602_II984602RF51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V62.2.480.480","article-title":"Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura","volume":"62","author":"Bussel","year":"1983","journal-title":"Blood"},{"key":"10.1006\/clin.1998.4602_II984602RF52","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","article-title":"Transiet reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous gammaglobulin","volume":"306","author":"Fehr","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4602_II984602RF53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.132.2.745","article-title":"Modulation of mononuclear phagocyte function by intravenous gammaglobulin","volume":"132","author":"Kimberly","year":"1984","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1998.4602_II984602RF54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1998.4602_II984602RF55","series-title":"The Biology of the Guinea Pig","first-page":"79","author":"Sisk","year":"1976"}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122998946025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122998946025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:08:56Z","timestamp":1758762536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122998946025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["S0090122998946025"],"URL":"https:\/\/doi.org\/10.1006\/clin.1998.4602","relation":{},"ISSN":["0090-1229"],"issn-type":[{"type":"print","value":"0090-1229"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with Progesterone Analogues Decreases Macrophage Fc\u03b3 Receptors Expression","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1998.4602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}